PIK3R2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.001200E-01
Normal-vs-Stage2
8.523800E-01
Normal-vs-Stage3
7.031000E-01
Normal-vs-Stage4
3.423200E-01
Stage1-vs-Stage2
7.708600E-01
Stage1-vs-Stage3
4.808000E-01
Stage1-vs-Stage4
5.111000E-01
Stage2-vs-Stage3
3.102400E-01
Stage2-vs-Stage4
2.275000E-01
Stage3-vs-Stage4
2.085800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.316000E-01
Normal-vs-AfricanAmerican
7.630000E-01
Normal-vs-Asian
6.334400E-01
Caucasian-vs-AfricanAmerican
3.728000E-01
Caucasian-vs-Asian
8.160200E-01
AfricanAmerican-vs-Asian
2.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.880400E-01
Normal-vs-Female
6.862400E-01
Male-vs-Female
4.280400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.661200E-01
Normal-vs-Age(41-60Yrs)
4.863400E-01
Normal-vs-Age(61-80Yrs)
8.842000E-01
Normal-vs-Age(81-100Yrs)
5.731000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.525800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.126000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.412600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.134590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.518200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.878400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.778200E-01
Normal-vs-Daily Drinker
9.407000E-01
Normal-vs-Weekly Drinker
4.201400E-01
Normal-vs-Occasional Drinker
4.526600E-01
Normal-vs-Social Drinker
5.855800E-01
Non Drinker-vs-Daily Drinker
3.015200E-01
Non Drinker-vs-Weekly Drinker
2.046100E-02
Non Drinker-vs-Occasional Drinker
2.913900E-02
Non Drinker-vs-Social Drinker
5.967900E-02
Daily Drinker-vs-Weekly Drinker
2.063200E-01
Daily Drinker-vs-Occasional Drinker
1.121640E-01
Daily Drinker-vs-Social Drinker
3.989400E-01
Weekly Drinker-vs-Occasional Drinker
4.584800E-01
Weekly Drinker-vs-Social Drinker
6.616600E-01
Occasional Drinker-vs-Social Drinker
3.040800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.794400E-01
Normal-vs-Grade 2
5.367800E-01
Normal-vs-Grade 3
1.422370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.546800E-01
Grade 1-vs-Grade 3
4.414000E-01
Grade 1-vs-Grade 4
2.794400E-01
Grade 2-vs-Grade 3
6.504800E-01
Grade 2-vs-Grade 4
5.367800E-01
Grade 3-vs-Grade 4
1.422370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.769400E-01
Normal-vs-NonDiabetic
6.648600E-01
Diabetic-vs-NonDiabetic
1.855990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.151200E-01
Normal-vs-NoPancreatitis
7.364200E-01
Pancreatitis-vs-NoPancreatitis
6.278200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.645400E-01
Normal-vs-N1
8.435600E-01
N0-vs-N1
2.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.490400E-01
Normal-vs-TP53-NonMutant
7.153000E-01
TP53-Mutant-vs-TP53-NonMutant
3.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
